{"id":100726,"date":"2026-03-04T23:26:41","date_gmt":"2026-03-04T22:26:41","guid":{"rendered":"https:\/\/tst.kathama.com\/?post_type=product&p=100726"},"modified":"2026-10-15T23:47:42","modified_gmt":"2026-10-15T21:47:42","slug":"igf-1-lr3-1mg","status":"publish","type":"product","link":"https:\/\/tst.kathama.com\/sk\/product\/igf-1-lr3-1mg\/","title":{"rendered":"IGF-1 LR3 1mg"},"content":{"rendered":"

IGF-1 LR3 1mg is a highly specialised synthetic analogue of insulin-like growth factor-1, engineered for extended half-life and potency in cellular research. With an 83-amino-acid structure including arginine substitution at position 3 and a 13-amino-acid N-terminal extension, IGF-1 LR3 supports investigations into muscle hypertrophy, tissue regeneration, and metabolic regulation via IGF-1 receptor activation.Ko ietver m\u016bsu autentiskuma sertifik\u0101ti<\/span><\/p>","protected":false},"excerpt":{"rendered":"

IGF-1 LR3 1mg is a highly specialised synthetic analogue of insulin-like growth factor-1, engineered for extended half-life and potency in cellular research. With an 83-amino-acid structure including arginine substitution at position 3 and a 13-amino-acid N-terminal extension, IGF-1 LR3 supports investigations into muscle hypertrophy, tissue regeneration, and metabolic regulation via IGF-1 receptor activation.\u200b<\/span><\/p>\n

IGF-1 LR3 1mg is frequently examined in models of muscle growth, injury recovery, and anabolic signalling. Its reduced binding to IGFBPs enables prolonged activity, making it suitable for studies on protein synthesis, myoblast proliferation, fat metabolism, and PI3K\/Akt pathway modulation under anabolic or repair conditions. Due to its enhanced bioavailability, IGF-1 LR3 is often selected for research into hyperplasia, glucose uptake, and tissue repair mechanisms in preclinical settings.<\/p>\n

Key Features<\/h2>\n